Clinical Trial Update: Expanded Access Program for GBM Subjects

View source ↗

Summary

This update notes an expanded access program for glioblastoma patients sponsored by Rznomics, Inc., and it is currently available for eligible subjects.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Snippet

Sponsor: Rznomics, Inc. | Conditions: Glioblastoma | Status: AVAILABLE